Showing 4,241 - 4,260 results of 18,529 for search 'significantly ((((((lower decrease) OR (larger decrease))) OR (a decrease))) OR (greater decrease))', query time: 0.82s Refine Results
  1. 4241
  2. 4242

    Table 1_Genetic variants in the vitamin D pathway genes are predictors of the risk of diabetic kidney disease in Central Asian Kazakhstani cohort with type 2 diabetes.docx by Binura Taurbekova (21692555)

    Published 2025
    “…</p>Results<p>The CYP27A1 rs17470271 T/T genotype was significantly associated with a reduced risk of DKD under the recessive model (AOR = 0.32, 95% CI: 0.11–0.93). …”
  3. 4243
  4. 4244
  5. 4245
  6. 4246

    S1 Graphical abstract - by Hai Nguyen Ngoc Dang (19200560)

    Published 2024
    “…A longer diabetes duration was linked to a greater ASI (r = 0.43, p < 0.05), while the AS decreased (r = -0.37, p < 0.05).…”
  7. 4247

    Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

    Published 2025
    “…Beginning from day 28, when the solid tumors are of ~100mm<sup>3</sup> size, control and experimental mice were administered with drugs every other day for 18 days (total duration 46 days); on day 46, the mice were sacrificed and blood, vital organs and tumors were harvested for further analysis (b) Administration of STZ increased fasting blood sugar in mice: In order to establish hyperglycaemic state, mice were administered with low-dose STZ as detailed in methods section and blood sugar content determined using Morepen glucose monitoring strips. The data showed a significant increase in fasting blood glucose (FBG) beginning from day 6. …”
  8. 4248
  9. 4249
  10. 4250

    Distribution of Pre-existing Medical Conditions. by Sepideh Hejazi (16227860)

    Published 2025
    “…</p><p>Results</p><p>Initial clinical presentations differed significantly, eneralized Estimating Equations (GEE) analysis, adjusted for comorbidities, revealed COVID-19 history was associated with increased platelet counts <i>(P</i> = 0.0311) and decreased facial swelling <i>(P</i> = 0.049) and fever symptom reporting <i>(P</i> < 0.001). …”
  11. 4251
  12. 4252
  13. 4253
  14. 4254
  15. 4255

    Characteristics of the study participants. by Michał Wendt (17601180)

    Published 2025
    “…No significant changes were observed in the control group, although a trend toward lower pain levels was noted in the experimental group after intervention.…”
  16. 4256

    Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study by Abdullah AlOmier (20402765)

    Published 2024
    “…To address this limitation, a novel approach was employed that combined photolithography and molecular vapor deposition of perfluorodecyltrichlorosilane to precisely and selectively modify wettability within specific pore regions, achieving a mixed wettability distribution correlated with pore size for the first time. …”
  17. 4257

    Experimental Investigation of the Impact of Mixed Wettability on Pore-Scale Fluid Displacement: A Microfluidic Study by Abdullah AlOmier (20402765)

    Published 2024
    “…To address this limitation, a novel approach was employed that combined photolithography and molecular vapor deposition of perfluorodecyltrichlorosilane to precisely and selectively modify wettability within specific pore regions, achieving a mixed wettability distribution correlated with pore size for the first time. …”
  18. 4258

    Model selection based on best fit. by Angelina Mageni Lutambi (22097223)

    Published 2025
    “…<div><p>Malaria remains a significant public health challenge, particularly among vulnerable populations in high-burden countries like Tanzania. …”
  19. 4259
  20. 4260

    Table 1_LpxR and PagL expression in live attenuated auxotrophic Pseudomonas aeruginosa vaccines modulates lipid A reactogenicity in vitro while preserving immunogenicity.docx by Miriam Moscoso (345679)

    Published 2025
    “…We previously developed a live attenuated auxotrophic vaccine candidate, PAO1 ΔmurI, which conferred protection in murine infection models but exhibited significant reactogenicity when administered intranasally. …”